Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan in Hypertension, Obesity, or Type 2 Diabetes
NCT02235519Phase 3Unknown
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Jan 2014
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azilsartan medoxomil in hypertension (HTN), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Status: unknown.
02
Drugs
azilsartan medoxomil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02235519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235519.